ArticleHuman gene therapy2020

Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery.

Michael J Castle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.